GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » ROE % Adjusted to Book Value

ANTCF (Aion Therapeutic) ROE % Adjusted to Book Value : 0.00% (As of Oct. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic ROE % Adjusted to Book Value?

Aion Therapeutic's ROE % for the quarter that ended in Oct. 2024 was 0.00%. Aion Therapeutic's PB Ratio for the quarter that ended in Oct. 2024 was N/A. Aion Therapeutic's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 was N/A.


Aion Therapeutic ROE % Adjusted to Book Value Historical Data

The historical data trend for Aion Therapeutic's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic ROE % Adjusted to Book Value Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - -26.71 - - -

Aion Therapeutic Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aion Therapeutic's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aion Therapeutic's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's ROE % Adjusted to Book Value falls into.


;
;

Aion Therapeutic ROE % Adjusted to Book Value Calculation

Aion Therapeutic's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Aion Therapeutic's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aion Therapeutic ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.